News
-
-
COMMUNIQUÉ DE PRESSE
Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo
NanoViricides, Inc. registers successful Phase II Clinical Trial of NV-387 Oral Gummies for Ebola viruses treatment in DRC. Prof. Patrick de Marie Chimusa Katoto leads the trial, expecting dosing in 1-2 weeks -
COMMUNIQUÉ DE PRESSE
Rapport financier semestriel 2026
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Logic Instrument et sa filiale Distrame transforment l'IoT de terrain avec NIDIS, un hub universel pour sécuriser les sites sensibles
Logic Instrument lance NIDIS, programme d'innovation IoT sécurisant les lieux sensibles avec soutien financier de Bpifrance. Solution modulaire et souveraine pour divers marchés -
COMMUNIQUÉ DE PRESSE
Emerald Horizon and VDL Groep start building the heart of the Small Modular Reactor SMRX
Emerald Horizon and VDL Groep start building the heart of the Small Modular Reactor SMRX in Eindhoven, showcasing innovative subcritical thorium-based energy source with high-temperature circuit and industrial partnership
